TheJournalofMusculoskeletalMedicine Members: Login | Register
TheJournalofMusculoskeletalMedicine SearchMedica Medline Drugs

Powered by SearchMedica

 
Conferences
News
In the Journals
Gout
Osteoarthritis
Osteoporosis
Rheumatoid Arthritis
Multimedia
Photo Quiz
 


The Journal of Respiratory Diseases.
 

Early RA Remission More Likely in Men Than in Women

July 11, 2012
Jawaheer D, Messing S, Reed G et alMen are significantly more likely than women to achieve sustained remission in the CORRONA Cohort of rheumatoid arthritis patientsArthritis Care Res (Hoboken). 2012 Jun 21. doi: 10.1002/acr.21762. [Epub ahead of print]

In patients with early rheumatoid arthritis (RA), sustained remission is more likely to be achieved in men than in women, a recent study found. However, sustained remission did not occur more frequently in men in the study who had established RA.

For the present analyses, researchers selected patients who had been enrolled in the CORRONA (Consortium of Rheumatology Researchers of North America) cohort between October 2001 and January 2010 and evaluated detailed clinical, demographic, and drug use data. They examined the influence of sex on Clinical Disease Activity Index remission and stratified data by RA duration at baseline to investigate whether RA duration had differential effects on remission in men and women.

(MORE: Cost-Effectiveness of Early RA Drug Strategies Analyzed)

In both early and established RA, women had more severe disease at baseline, with worse disease activity measures and modified Health Assessment Questionnaire Disability Index, pain visual analog scale, and depression scores. Treatment with disease-modifying antirheumatic drugs and anti-tumor necrosis factor therapy was more common in women than in men. The study appeared in the online version of Arthritis Care & Research, an American College of Rheumatology publication.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

This article reviewed

New Biomarker Test for RA Correlates With Known Disease Indicators

Structured Early RA Intervention Programs More Effective

Cost-Effectiveness of Early RA Drug Strategies Analyzed






 
TOPIC INDEX

  • Arthritis
  • Fibromyalgia
  • Geriatrics
  • Gout
  • Imaging
  • Juvenile Arthritis
  • Lupus
  • Osteoarthritis
  • Osteoporosis
  • Pain
  • Rheumatoid Arthritis
  • Women


 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent

  • Iontophoretic Administration of Dexamethasone for Musculoskeletal Pain
  • Managing degenerative lumbar spinal stenosis
  • Evaluating edema of the hands
  • Iliopsoas Bursitis
  • Rash Questions for Rheumatologists
  • Diagnosis and Management of Complex Regional Pain Syndrome
  • Botox Adds New Wrinkle to Debated Hyaluronic Acid Treatments for Knee OA
  • OARSI Adopts Tests for Physical Function in Hip and Knee OA
  • Idiopathic Chilblains
  • AAOS Weighs in Against Hyaluronic Acid for Knee OA
  • Quick Relapse After Stopping TNF Inhibitors in Peripheral Spondylitis
  • OK to Cut Back TNF-Alpha Blockers in Stable Ankylosing Spondylitis
  • In Primary Sjögrens, Hydroxychloroquine Ineffective in Short-Term
  • International Consensus on Treatment Targets for Spondyloarthritis and Psoriatic Arthritis
  • Off-Label Rituximab for Lupus in Europe: Used Seldom, But Widely
Click here to subscribe to our newsletter





CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy